9-15465569-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000380733.9(PSIP1):āc.1544A>Gā(p.Glu515Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000768 in 1,432,776 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 33)
Exomes š: 0.0000077 ( 0 hom. )
Consequence
PSIP1
ENST00000380733.9 missense
ENST00000380733.9 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.82
Genes affected
PSIP1 (HGNC:9527): (PC4 and SRSF1 interacting protein 1) Enables DNA-binding transcription factor binding activity; chromatin binding activity; and transcription coactivator activity. Involved in mRNA 5'-splice site recognition and positive regulation of transcription by RNA polymerase II. Located in heterochromatin; nuclear periphery; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
SNAPC3 (HGNC:11136): (small nuclear RNA activating complex polypeptide 3) Predicted to enable RNA polymerase III type 3 promoter sequence-specific DNA binding activity and bent DNA binding activity. Predicted to contribute to RNA polymerase II cis-regulatory region sequence-specific DNA binding activity and core promoter sequence-specific DNA binding activity. Predicted to be involved in snRNA transcription by RNA polymerase II and snRNA transcription by RNA polymerase III. Located in nuclear body and nucleolus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.13375276).
BS2
High AC in GnomAdExome4 at 11 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSIP1 | NM_033222.5 | c.1544A>G | p.Glu515Gly | missense_variant | 16/16 | ENST00000380733.9 | NP_150091.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSIP1 | ENST00000380733.9 | c.1544A>G | p.Glu515Gly | missense_variant | 16/16 | 1 | NM_033222.5 | ENSP00000370109 | P1 | |
PSIP1 | ENST00000380738.8 | c.1544A>G | p.Glu515Gly | missense_variant | 16/16 | 1 | ENSP00000370114 | P1 | ||
SNAPC3 | ENST00000610884.4 | c.*808T>C | 3_prime_UTR_variant | 12/12 | 1 | ENSP00000483273 | P1 | |||
SNAPC3 | ENST00000467062.5 | c.*808T>C | 3_prime_UTR_variant, NMD_transcript_variant | 12/12 | 1 | ENSP00000436699 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.0000123 AC: 3AN: 243608Hom.: 0 AF XY: 0.0000228 AC XY: 3AN XY: 131768
GnomAD3 exomes
AF:
AC:
3
AN:
243608
Hom.:
AF XY:
AC XY:
3
AN XY:
131768
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000768 AC: 11AN: 1432776Hom.: 0 Cov.: 29 AF XY: 0.0000112 AC XY: 8AN XY: 713952
GnomAD4 exome
AF:
AC:
11
AN:
1432776
Hom.:
Cov.:
29
AF XY:
AC XY:
8
AN XY:
713952
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | The c.1544A>G (p.E515G) alteration is located in exon 16 (coding exon 15) of the PSIP1 gene. This alteration results from a A to G substitution at nucleotide position 1544, causing the glutamic acid (E) at amino acid position 515 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MutPred
Loss of helix (P = 0.0237);Loss of helix (P = 0.0237);
MVP
MPC
0.16
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at